Core Viewpoint - The announcement highlights a strategic partnership between the company and Beijing Dekai Pharmaceutical Technology Co., Ltd. for the exclusive sales agency of the company's anti-foaming agent products in the mainland China market [1] Group 1: Partnership Details - The company’s wholly-owned subsidiary, Kaixi Hong Kong Limited, has entered into an exclusive sales agency agreement with Dekai Pharmaceutical [1] - The agreement focuses on the sales agency and market promotion of the company's anti-foaming agent products in mainland China [1] Group 2: Strategic Objectives - Both parties aim to leverage their respective advantages and resources to establish a close cooperative relationship [1] - The collaboration is intended to drive business development and product extension, achieving complementary advantages and synergistic growth [1]
开拓药业-B(09939.HK)与德开医药就防脱泡沫剂产品签订独家销售代理协议